Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
545.80
Change Change %
-0.30 -0.05%

Updated:25 Jun, 2019, 12:04 PM IST

BSE
537.15
Change Change %
-9.15 -1.67%

Updated:25 Jun, 2019, 12:41 PM IST

Natco Pharma's Financial Summary

View last 5 years Financial Summary

Parameter MAR'18
(₹ Cr.)
MAR'17
(₹ Cr.)
Change %
Net Profit Before Taxes 887.60 634.10 39.98%
Adjustments for Expenses & Provisions 74.40 99.80 -25.45%
Adjustments for Liabilities & Assets -281.20 -281.70 0.18%
Cash Flow from operating activities 476.40 329.80 44.45%
Cash Flow from investing activities -1,131.10 -290.60 -289.23%
Cash Flow from financing activities 652.00 -45.60 1529.82%
Effect of exchange fluctuation on translation reserve 0.00 0.00 0.00%
Net increase/(decrease) in cash and cash equivalents -2.70 -6.40 57.81%
Opening Cash & Cash Equivalents 12.80 19.20 -33.33%
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0.00 0.00 0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations 0.00 0.00 0.00%
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0.00 0.00 0.00%
Effect of Foreign Exchange Fluctuations 0.00 0.00 0.00%
Closing Cash & Cash Equivalent 10.10 12.80 -21.09%
Top